Abstract:The crystal and molecular structure of 7-dimethylamino-4-hydroxycoumarin as its hydrate ( 1 , C 11 H 11 NO 3 • H 2 O) has been determined. Crystals are monoclinic, space group P 2(1)/ n with a = 7.1435(4) Å, b = 20.1763(6) Å, c = 7.8590(3) Å, β = 110.018(5) o and V = 1064.28(8)Å 3 for 4 formula units per cell. Both coumarin enol ester hydroxy and carboxy groups engage in hydrogen-bonding with the water of crystallization. Several 3-substituted derivatives were prepared from this material including 7-dimethylamino-3-benzyl-4-hydroxycoumarin ( 2 ) and 7-dimethylaminowarfarin ( 4 ). Compound 2 (C 18 H 16 NO 3 ) crystallizes in the triclinic system, space group P -1, with a = 7.0180(7) Å, b = 7.8143(7) Å, c = 14.3158(10) Å, α = 90.586(6) o , β = 94.738(5) o , γ = 104.639(7) o , and V = 756.57(9) Å 3 for 2 molecules in the cell. For compound 2 , the crystal structure shows infinite hydrogen-bonded translational β-chains linking well aligned hydroxy and ester carboxy groups with a repeat distance of 7.018 Å. The dipolar nature of the substituted 4-hydroxycoumarin strengthens the β-chains compared to unsubstituted systems in which the repeat is longer and weaker at 7.17 Å. Computations (DFT) support the bond length changes due to a dipolar influence of the 7-dimethylamino group (compared to the unsubstituted compounds), and a more negative carboxy oxygen hydrogen-bond acceptor. For compound 4 (C 21 H 21 NO 4 ), a stereoselective synthesis allowed preparation of the (S)-isomer which crystallized in the orthorhombic system, space group P 2(1)2(1)2(1), with a = 6.7857(3) Å, b = 14.7140(5) Å, c = 17.4652(7) Å and V = 1743.81(12) Å 3 for 4 molecules in the cell. Compound 4 forms the trans cyclic hemiketal from methanol in the crystal. In CDCl 3 solution (298 K), 4 exists as an equilibrium mixture of three tautomers: 12.8% open form, 45.5% cis hemiketal and 41.7% trans hemiketal (coumarin forms).

4-(N,n-dimethylamino)-3-(2,2-diphenylethenyl)coumarin

7-Dimethylamino-4-Hydroxycoumarin and Derivatives: Enhanced β-Chain Hydrogen-Bonding

3-(4-Methoxystyryl)-2h-1,4-benzoxazin-2-one

4-(Pyridin-2-yl)-1,3-dithiol-2-one.

(4R)-Ethyl 4-(4-Chlorophenyl)-2-hydroxy-5-oxo-2,3,4,5-tetrahydropyrano[3,2-c]chromene-2-carboxylate

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

Dimethyl 2-(4-Fluorophenyl)-3-(methylamino)-furan-4,5-dicarboxylate

N '-[(E)-2-hydroxybenzylidene]-5-methylisoxazole-4-carbohydrazide Monohydrate

2-Methyl-2-(trimethylsilyloxy)-3,4-dihydro-2h,5h-pyrano[3,2-c][1]benzopyran-5-one

2,4-Diphenyl-2-(trimethylsilyloxy)-3-dihydro-2h, 5H-Pyrano[3,2-c][1] Benzopyran-5-One

N -[4-(Dimethylamino)benzylidene]-4-methylbenzenesulfonamide

N-[4-(Dimethylamino)Benzylidene]-4-Methylbenzene-Sulfonamide

(E)-Dimethyl 4-(Ethylamino)-5-styrylfuran-2,3-dicarboxylate

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(E)-Dimethyl 4-butylamino-5-(4-methylstyryl)-furan-2,3-dicarboxylate

4-[4-Dimethylamino-1-(4-fluorophenyl)-1-hydroxy-butyl]-3-(hydroxymethyl) Benzonitrile

4-(4-Cyano-2-fluorophenoxy)phenyl 4-Methylbenzenesulfonate

4-Bromo-1-[2,6-dichloro-4-(trifluoromethyl)-phenyl]-5-[(2-furyl) Methyleneamino]-1h-Pyrazole-3-Carbonitrile

N,N'-(4,5-Dichloro-o-phenylene)bis(4-tert-butylpyridine-2-carboxamide)

2-Dipentylamino-4-(4-methoxybenzyl-idene)-1-phenyl-1H-imidazol-5(4H)-one

4-(2,3,4-Trimethoxy-6-methylbenzylideneamino)phenol